Literature DB >> 26969580

Interleukin-33: increasing role in dermatological conditions.

Anna Balato1, Annunziata Raimondo2, Nicola Balato2, Fabio Ayala2, Serena Lembo2.   

Abstract

Interleukin-33 is a novel and an unconventional member of IL-1 family. It is an inflammation-induced factor with dual function exercising its role as an intracellular regulator of gene expression, as well as, an extracellular alarm mediator. It is a ligand for ST2, a heterodimeric membrane-bound receptor of the orphan IL-1 family receptor. Interleukin-33/ST2 signaling has been studied in a wide range of inflammatory skin conditions for its crucial role in immune responses and tissue homeostasis. In this review, we report the current knowledge regarding the complex biology of interleukin-33 and its function in the skin and in clinical settings.

Entities:  

Keywords:  IL-33; Immunity; ST2; Skin diseases

Mesh:

Substances:

Year:  2016        PMID: 26969580     DOI: 10.1007/s00403-016-1638-7

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  3 in total

Review 1.  Possible Roles of IL-33 in the Innate-Adaptive Immune Crosstalk of Psoriasis Pathogenesis.

Authors:  Serafinella Patrizia Cannavò; Lucrezia Bertino; Eleonora Di Salvo; Valeria Papaianni; Elvira Ventura-Spagnolo; Sebastiano Gangemi
Journal:  Mediators Inflamm       Date:  2019-10-14       Impact factor: 4.711

2.  The Effects of Vitamin D on the Expression of IL-33 and Its Receptor ST2 in Skin Cells; Potential Implication for Psoriasis.

Authors:  Justyna M Wierzbicka; Anna Piotrowska; Dorota Purzycka-Bohdan; Anna Olszewska; Joanna I Nowak; Aneta Szczerkowska-Dobosz; Bogusław Nedoszytko; Roman J Nowicki; Michał A Żmijewski
Journal:  Int J Mol Sci       Date:  2021-11-29       Impact factor: 5.923

Review 3.  Polymorphic Light Eruption: What's New in Pathogenesis and Management.

Authors:  Serena Lembo; Annunziata Raimondo
Journal:  Front Med (Lausanne)       Date:  2018-09-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.